| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12026-017-8927-X |
| P698 | PubMed publication ID | 28508945 |
| P2093 | author name string | Hai-Bo Li | |
| Ming-Jie Zhang | |||
| Xiao-Hua Wang | |||
| Mao Lin | |||
| Ji-Bing Chen | |||
| Ke-Cheng Xu | |||
| Li-Zhi Niu | |||
| Shu-Zhen Liang | |||
| Ying-Qing Liang | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 | ||
| Anti-West Nile virus activity of in vitro expanded human primary natural killer cells | Q27490927 | ||
| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
| In search of the 'missing self': MHC molecules and NK cell recognition | Q28250846 | ||
| Reporting results of cancer treatment | Q29620070 | ||
| Image-guided tumor ablation: standardization of terminology and reporting criteria | Q31161842 | ||
| Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma | Q33358110 | ||
| NK cell-based immunotherapy for malignant diseases | Q33827433 | ||
| Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer | Q35144659 | ||
| Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway | Q35787150 | ||
| Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells | Q35847820 | ||
| Killer immunoglobulin-like receptors | Q35876789 | ||
| Cryosurgery for lung cancer | Q36186325 | ||
| The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation | Q36344170 | ||
| Biological role of NK cells and immunotherapeutic approaches in breast cancer | Q36460884 | ||
| Mechanisms of immune evasion by tumors | Q36490750 | ||
| Prospects for the use of NK cells in immunotherapy of human cancer. | Q36793616 | ||
| A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer | Q37141237 | ||
| Current state of urological cryosurgery: prostate and kidney | Q37690883 | ||
| How I do it: radiofrequency ablation and cryoablation of lung tumors | Q37867440 | ||
| Immunotherapies for non-small-cell lung cancer and mesothelioma. | Q38022807 | ||
| Adjuvant treatment of resected nonsmall cell lung cancer: state of the art and new potential developments | Q38069429 | ||
| Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer | Q38098498 | ||
| Non-small-cell lung cancers: a heterogeneous set of diseases | Q38233321 | ||
| Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients | Q38825476 | ||
| miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer | Q38944644 | ||
| Cryosurgery for malignant endobronchial tumors: analysis of outcome | Q39365955 | ||
| HLA-Cw4 expression on porcine endothelial cells reduces cytotoxicity and adhesion mediated by CD158a+ human NK cells | Q39879752 | ||
| Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors | Q40262316 | ||
| Combination of cryosurgery and Iodine-125 seeds brachytherapy for lung cancer | Q41908000 | ||
| Epitope of titin A-band-specific monoclonal antibody Tit1 5 H1.1 is highly conserved in several Fn3 domains of the titin molecule. Centriole staining in human, mouse and zebrafish cells | Q42658419 | ||
| Prognostic value of peripheral and local forkhead box P3(+) regulatory T cells in patients with non-small-cell lung cancer | Q42743141 | ||
| A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer | Q42940016 | ||
| Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer | Q46056802 | ||
| Adjuvant chemotherapy for non-small-cell lung cancer--the smoke clears | Q46562044 | ||
| The application of cryosurgery in the treatment of lung cancer | Q48018718 | ||
| Percutaneous cryoablation for pulmonary nodules in the residual lung after pneumonectomy: report of two cases. | Q53187080 | ||
| Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. | Q53438311 | ||
| IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. | Q53925120 | ||
| Role of Intraoperative Thermoablation Combined With Resection in the Treatment of Hepatic Metastasis From Colorectal Cancer | Q57823561 | ||
| Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria | Q60150062 | ||
| A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group | Q73172914 | ||
| Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer | Q73475225 | ||
| KIR/HLA ligand incompatibility in kidney transplantation | Q80228070 | ||
| The acute effects of transthoracic cryoablation on normal lung evaluated in a porcine model | Q81202503 | ||
| Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma | Q83393563 | ||
| Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients | Q84489773 | ||
| The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients | Q87157814 | ||
| P433 | issue | 4 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 880-887 | |
| P577 | publication date | 2017-05-16 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer. | |
| P478 | volume | 65 |
| Q90681174 | Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors |
| Q64051980 | Cryoablation and immunotherapy: an overview of evidence on its synergy |
| Q92379222 | Immune cell therapy for hepatocellular carcinoma |
| Q58764532 | Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy |
| Q89574416 | Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients |
| Q91906006 | Preparation of highly activated natural killer cells for advanced lung cancer therapy |
| Q52608280 | Role of natural killer cells in lung cancer. |
| Q89921619 | [Minimally Invasive Therapies For Early Stage Non-Small Cell Lung Cancer] |
Search more.